361 related articles for article (PubMed ID: 32478016)
21. C3 glomerulopathy and current dilemmas.
Ito N; Ohashi R; Nagata M
Clin Exp Nephrol; 2017 Aug; 21(4):541-551. PubMed ID: 27878657
[TBL] [Abstract][Full Text] [Related]
22. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics?
Javaid B; Quigg RJ
Kidney Int; 2005 May; 67(5):1692-703. PubMed ID: 15840015
[TBL] [Abstract][Full Text] [Related]
23. Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches.
Gómez-Guerrero C; Hernández-Vargas P; López-Franco O; Ortiz-Muñoz G; Egido J
Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):341-51. PubMed ID: 16101544
[TBL] [Abstract][Full Text] [Related]
24. Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy.
Wada Y; Kamata M; Miyasaka R; Abe T; Kawamura S; Takeuchi K; Aoyama T; Oda T; Takeuchi Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176142
[TBL] [Abstract][Full Text] [Related]
25. All Things Complement.
Thurman JM; Nester CM
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1856-1866. PubMed ID: 27340286
[TBL] [Abstract][Full Text] [Related]
26. A clinical approach to children with C3 glomerulopathy.
Vivarelli M; van de Kar N; Labbadia R; Diomedi-Camassei F; Thurman JM
Pediatr Nephrol; 2022 Mar; 37(3):521-535. PubMed ID: 34002292
[TBL] [Abstract][Full Text] [Related]
27. Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases.
Koubar SH; Garcia-Rivera A; Mohamed MMB; Hall JE; Hall ME; Hassanein M
Curr Hypertens Rep; 2024 Mar; 26(3):119-130. PubMed ID: 37982994
[TBL] [Abstract][Full Text] [Related]
28. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
29. Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction.
Doumas SA; Tsironis C; Bolaji AA; Garantziotis P; Frangou E
Autoimmun Rev; 2023 Jun; 22(6):103327. PubMed ID: 36990134
[TBL] [Abstract][Full Text] [Related]
30. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy.
Couser WG
Am J Kidney Dis; 1988 Jun; 11(6):449-64. PubMed ID: 3287904
[TBL] [Abstract][Full Text] [Related]
31. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
[TBL] [Abstract][Full Text] [Related]
32. Current status and issues of C1q nephropathy.
Mii A; Shimizu A; Masuda Y; Fujita E; Aki K; Ishizaki M; Sato S; Griesemer A; Fukuda Y
Clin Exp Nephrol; 2009 Aug; 13(4):263-274. PubMed ID: 19373520
[TBL] [Abstract][Full Text] [Related]
33. The local production of complement in the pathogenesis of renal inflammation.
Sheerin NS; Sacks SH
Nephrologie; 1999; 20(7):377-82. PubMed ID: 10642986
[TBL] [Abstract][Full Text] [Related]
34. Glomerular antigens in glomerulonephritis.
Neale TJ; Wilson CB
Springer Semin Immunopathol; 1982; 5(3):221-49. PubMed ID: 6223391
[TBL] [Abstract][Full Text] [Related]
35. Sex and Gender in Glomerular Disease.
Beckwith H; Lightstone L; McAdoo S
Semin Nephrol; 2022 Mar; 42(2):185-196. PubMed ID: 35718365
[TBL] [Abstract][Full Text] [Related]
36. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
Kant S; Kronbichler A; Sharma P; Geetha D
Am J Kidney Dis; 2022 Apr; 79(4):582-600. PubMed ID: 34508831
[TBL] [Abstract][Full Text] [Related]
37. The complement system in IgAN: mechanistic context for therapeutic opportunities.
Duval A; Caillard S; Frémeaux-Bacchi V
Nephrol Dial Transplant; 2023 Nov; 38(12):2685-2693. PubMed ID: 37385820
[TBL] [Abstract][Full Text] [Related]
38. Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis.
Cunningham MA; Huang XR; Dowling JP; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 1999 Mar; 10(3):499-506. PubMed ID: 10073600
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of glomerulonephritis.
Couser WG
Kidney Int Suppl; 1993 Jul; 42():S19-26. PubMed ID: 8361123
[TBL] [Abstract][Full Text] [Related]
40. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
Xie X; Liu P; Gao L; Zhang X; Lan P; Bijol V; Lv J; Zhang H; Jin J
J Pathol; 2021 Jun; 254(2):159-172. PubMed ID: 33660264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
